Concurrent RB1 Loss and <i>BRCA</i> Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma
Flurina A.M. Saner(University of Bern), Jennifer M. Koziak(Alberta Health Services), Angela Brooks‐Wilson(BC Cancer Agency), Kazuaki Takahashi(Tokyo Shinagawa Hospital), Nicola S. Meagher(The University of Sydney), Timothy Budden(University of Manchester), Esther Elishaev(University of Pittsburgh), Penny Coulson(Institute of Cancer Research), Michael E. Carney(The University of Texas MD Anderson Cancer Center), Kara L. Cushing‐Haugen(Fred Hutch Cancer Center), Michael E. Jones(Institute of Cancer Research), Adelyn Bolithon(Cancer Institute of New South Wales), Brenda Y. Hernandez(Cancer Center of Hawaii), Gregg Nelson(Brigham and Women's Hospital), Marjorie J. Riggan(Duke Medical Center), Kathryn Alsop(Peter MacCallum Cancer Centre), C. Blake Gilks(Vancouver General Hospital), Elizabeth L. Christie(Peter MacCallum Cancer Centre), Mercedes Jimenez-Linan(Institute of Cancer Research), Matthias W. Beckmann(Universitätsklinikum Erlangen), Prafull Ghatage(University of Calgary), Simon A. Gayther(The University of Texas Health Science Center at Houston), Arndt Hartmann(Universitätsklinikum Erlangen), Therese Hoang(Peter MacCallum Cancer Centre), Catherine J. Kennedy(The University of Sydney), Aleksandra Gentry‐Maharaj(UCL Australia), Joy Hendley(Peter MacCallum Cancer Centre), Scott H. Kaufmann(Mayo Clinic), Eun-Young Kang(University of Calgary), Anna Jakubowska(Pomeranian Medical University), Sián Fereday(Peter MacCallum Cancer Centre), Jessica Boros(The University of Sydney), Holly R. Harris(Fred Hutch Cancer Center), Madeleine Courtney‐Brooks(University of Virginia Health System), Mona El‐Bahrawy(Al-Azhar University), Ahwan Pandey(Howard Hughes Medical Institute), Paul R. Harnett(The University of Sydney), Tibor A. Zwimpfer(University Hospital of Basel), Alison H. Brand(The University of Sydney), Kathleen I. Pishas(The University of Melbourne), Tomasz Kluz(University of Rzeszów), Alexander Hein, Cezary Cybulski(International Hereditary Cancer Center), Ramona Erber(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dinuka Ariyaratne(Peter MacCallum Cancer Centre), Cheng‐Han Lee(University of Alberta), Nadia Traficante(The University of Melbourne), Laura Twomey(Peter MacCallum Cancer Centre), Jennifer Alsop(Manchester Academic Health Science Centre)
Cited by 14
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas
|New England Journal of Medicine|2010|1.7k
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
|Nature Genetics|1999|1.7k
Whole–genome characterization of chemoresistant ovarian cancer
|Nature|2015|1.7k
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k